<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-21T11:27:53+08:00</updated>
  <subtitle>世事洞明皆学问，人情练达即文章</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>聚焦ASH2020：BTKi暗潮涌动</title>
    <updated>2020-11-21T08:33:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/86Af-lK0gFHuY0GbxUZHPQ</id>
    <link href="https://mp.weixin.qq.com/s/86Af-lK0gFHuY0GbxUZHPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>突破给药途径局限！新型溶瘤病毒疗法：可静脉注射，让PD-1抗体疗效更出众</title>
    <updated>2020-11-21T08:33:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/pIZD90MskgSD6WgWOHPtRA</id>
    <link href="https://mp.weixin.qq.com/s/pIZD90MskgSD6WgWOHPtRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：数据分析师（医药大数据方向）</title>
    <updated>2020-11-21T08:33:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/RrV3RlaI8WwloaJ7oC7q9Q</id>
    <link href="https://mp.weixin.qq.com/s/RrV3RlaI8WwloaJ7oC7q9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：市场数据分析师</title>
    <updated>2020-11-21T08:33:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/OaGJpw-AlJVqZfgR12OB3A</id>
    <link href="https://mp.weixin.qq.com/s/OaGJpw-AlJVqZfgR12OB3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛诺菲巴斯德新一代流感疫苗（重组四价流感疫苗） 在欧洲31国获批！用于18岁及以上成人的流感预防</title>
    <updated>2020-11-20T07:42:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/yEm0SV158FPAdP7U4Pc5yQ</id>
    <link href="https://mp.weixin.qq.com/s/yEm0SV158FPAdP7U4Pc5yQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日，德琪医药正式在港交所上市</title>
    <updated>2020-11-20T07:42:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/CO0V9IOXfNLll53N9uEOkw</id>
    <link href="https://mp.weixin.qq.com/s/CO0V9IOXfNLll53N9uEOkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亿腾医药宣布VASCEPA®中国III期临床研究取得积极结果</title>
    <updated>2020-11-20T07:42:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/E2GIkGx5uRHYgtR0RDw7YQ</id>
    <link href="https://mp.weixin.qq.com/s/E2GIkGx5uRHYgtR0RDw7YQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：数据分析师（疫苗方向）</title>
    <updated>2020-11-20T07:42:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/z3qrmlgsLl8cx_ZyWJMpYw</id>
    <link href="https://mp.weixin.qq.com/s/z3qrmlgsLl8cx_ZyWJMpYw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个国产ALK抑制剂！贝达药业「恩沙替尼」获批上市</title>
    <updated>2020-11-19T09:43:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/AJCNMtxVygZr4cmmAGH5qA</id>
    <link href="https://mp.weixin.qq.com/s/AJCNMtxVygZr4cmmAGH5qA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MSI-H/dMMR晚期实体瘤：各家PD-1/PD-L1表现如何？</title>
    <updated>2020-11-19T09:43:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/2oUfBvYFSRa_zS55fm_zOA</id>
    <link href="https://mp.weixin.qq.com/s/2oUfBvYFSRa_zS55fm_zOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：运营专员</title>
    <updated>2020-11-19T09:43:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/R6FS2fxi7NL6OZwrkrIu6w</id>
    <link href="https://mp.weixin.qq.com/s/R6FS2fxi7NL6OZwrkrIu6w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>铁打的Biotech，流水的CFO</title>
    <updated>2020-11-18T07:33:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/0RDsW2ieZJ6MaI3qsg3Xow</id>
    <link href="https://mp.weixin.qq.com/s/0RDsW2ieZJ6MaI3qsg3Xow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2个月注射1次，HIV暴露前预防效力提高66%！Cabotegravir获突破性疗法资格</title>
    <updated>2020-11-18T07:33:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/-NgrD15OSeidzI1PDdE9fw</id>
    <link href="https://mp.weixin.qq.com/s/-NgrD15OSeidzI1PDdE9fw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>替雷利珠单抗治疗非小细胞肺癌III期研究中期分析到达OS主要终点</title>
    <updated>2020-11-18T07:33:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/lcAFHUMTUJ4vBkDt7XW_3g</id>
    <link href="https://mp.weixin.qq.com/s/lcAFHUMTUJ4vBkDt7XW_3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：医学知识工程师</title>
    <updated>2020-11-18T07:33:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/3XpE4DUyqeWZ47jb1gBZKg</id>
    <link href="https://mp.weixin.qq.com/s/3XpE4DUyqeWZ47jb1gBZKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDK4/6抑制剂角逐早期乳腺癌：阿贝西利为何后来居上？</title>
    <updated>2020-11-17T07:40:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/AZ1QFL_lNZbWXxw1MBv5PQ</id>
    <link href="https://mp.weixin.qq.com/s/AZ1QFL_lNZbWXxw1MBv5PQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>破解PD1耐药黑色素瘤治疗难题！创新IL-12制剂+Keytruda客观缓解率达到30%</title>
    <updated>2020-11-17T07:40:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/P4XXdPPD-9amwOLvNRWBRg</id>
    <link href="https://mp.weixin.qq.com/s/P4XXdPPD-9amwOLvNRWBRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：客户服务经理</title>
    <updated>2020-11-17T07:40:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/uIx5wnk4z0Yd5dd6qKs-zw</id>
    <link href="https://mp.weixin.qq.com/s/uIx5wnk4z0Yd5dd6qKs-zw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品专利攻防战实力排行：恒瑞、天晴、石药位居前三</title>
    <updated>2020-11-16T07:40:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/j97rpx_jXyuNxvChttMknQ</id>
    <link href="https://mp.weixin.qq.com/s/j97rpx_jXyuNxvChttMknQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康朴生物医药在美国启动KPG-818 治疗系统性红斑狼疮Ib/IIa期临床试验</title>
    <updated>2020-11-16T07:40:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/8bg_UVoOKJmoYi-3GwouHQ</id>
    <link href="https://mp.weixin.qq.com/s/8bg_UVoOKJmoYi-3GwouHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>